2009 Form 990-PF - Bill & Melinda Gates Foundation

BILL & MELINDA GATES FOUNDATION 56-2618866
FORM 990PF, PART XV - GRANTS AND CONTRIBUTIONS PAID DURING THE YEAR
RELATIONSHIP TO SUBSTANTIAL CONTRIBUTOR
AND
ATTACHMENT 18 (CONT'D)
RECIPIENT NAME AND ADDRESS FOUNDATION STATUS OF RECIPIENT PURPOSE OF GRANT OR CONTRIBUTION AMOUNT
EMORY UNIVERSITY NONE TO SUPPORT THE INTERNATIONAL ASSOCIATION OF
4,369,952.
1599 CLIFTON RD NE 509(A)(1)
4TH FLOOR
ATLANTA, GA 30322
NATIONAL PUBLIC HEALTH INSTITUTES (IANPHI) IN
IMPROVING HEALTH IN LOW-RESOURCE COUNTRIES
EMORY UNIVERSITY NONE TO DEVELOP A SURVEY TO MEASURE KNOWLEDGE,
548,726.
1599 CLIFTON RD NE 509(A)(1)
4TH FLOOR
ATLANTA, GA 30322
ATTITUDES, AND PRACTICES OF VACCINE PROVIDERS
IN INDIA TO IDENTIFY THE MOST SIGNIFICANT
BARRIERS TO ACHIEVING HIGH IMMUNIZATION RATES
EMORY UNIVERSITY NONE GLYCANS ARE AN IMPORTANT COMPONENT OF SURFACE
100,000.
1599 CLIFTON RD NE 509(A)(1)
4TH FLOOR
ATLANTA, GA 30322
IN INDIA
MOLECULES IN TUBERCULOSIS BUT THEIR ROLE IN
PROTECTIVE IMMUNITY IS STILL LARGELY
UNEXPLORED. CARLOS RIVERA-MARRERO AND RICHARD
D. CUMMING OF EMORY UNIVERSITY IN THE U.S.
WILL DEVELOP HIGH-THROUGHPUT GLYCAN
MICROARRAYS TO IDENTIFY GLYCAN ANTIGENS,
DETERMINE THEIR CHEMICAL STRUCTURE, AND
DESIGN GLYCAN-PEPTIDE VACCINES FOR FUTURE
EMORY UNIVERSITY NONE TO DEVELOP PRIORITIES FOR A MATERNAL AND FETAL
2,005,747.
1599 CLIFTON RD NE 509(A)(1)
4TH FLOOR
ATLANTA, GA 30322
TESTING.
NUTRITION RESEARCH AND IMPLEMENTATION AGENDA
EMORY UNIVERSITY NONE TO DEMONSTRATE AND LEVERAGE THE UPTAKE OF
5,000,000.
1599 CLIFTON RD NE 509(A)(1)
4TH FLOOR
ATLANTA, GA 30322
FOR PUBLIC DISCLOSURE
78 OF 519
SCALABLE MODELS OF DELIVERY AND NEWBORN CARE
IN COMMUNITIES IN RURAL ETHIOPIA TO IMPROVE
MATERNAL AND NEWBORN SURVIVAL AND WELL-BEING
ATTACHMENT 18